ES2114681T3 - Tratamiento transdermico de cancer con camptotecina insoluble en agua en la forma de anillo de lactona cerrado. - Google Patents

Tratamiento transdermico de cancer con camptotecina insoluble en agua en la forma de anillo de lactona cerrado.

Info

Publication number
ES2114681T3
ES2114681T3 ES94907804T ES94907804T ES2114681T3 ES 2114681 T3 ES2114681 T3 ES 2114681T3 ES 94907804 T ES94907804 T ES 94907804T ES 94907804 T ES94907804 T ES 94907804T ES 2114681 T3 ES2114681 T3 ES 2114681T3
Authority
ES
Spain
Prior art keywords
camptothecin
treatment
insoluble
water
closed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94907804T
Other languages
English (en)
Inventor
Beppino C Giovanella
Hellmuth R Hinz
Anthony J Kozielski
John S Stehlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stehlin Foundation for Cancer Research
Original Assignee
Stehlin Foundation for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stehlin Foundation for Cancer Research filed Critical Stehlin Foundation for Cancer Research
Application granted granted Critical
Publication of ES2114681T3 publication Critical patent/ES2114681T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE PRESENTA UN METODO PARA EL TRATAMIENTO DE TIPOS ESPECIFICOS DE CANCER CON COMPUESTOS DE 20(S)-CAMPTOTECINA INSOLUBLES EN AGUA CON EL ANILLO DE LACTONA CERRADO INTACTOS Y/O DERIVADOS DEL MISMO. EL METODO INCLUYE LA ADMINISTRACION TRANSDERMICA DE LOS COMPUESTOS.
ES94907804T 1993-01-15 1994-01-14 Tratamiento transdermico de cancer con camptotecina insoluble en agua en la forma de anillo de lactona cerrado. Expired - Lifetime ES2114681T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US284493A 1993-01-15 1993-01-15

Publications (1)

Publication Number Publication Date
ES2114681T3 true ES2114681T3 (es) 1998-06-01

Family

ID=21702794

Family Applications (3)

Application Number Title Priority Date Filing Date
ES02015200T Expired - Lifetime ES2301590T3 (es) 1993-01-15 1994-01-14 Utilizacion de camptotecina insoluble en agua en la forma de anillo de lactona cerrado para la obtencion de un medicamento para el tratamiento del cancer de colon.
ES94907804T Expired - Lifetime ES2114681T3 (es) 1993-01-15 1994-01-14 Tratamiento transdermico de cancer con camptotecina insoluble en agua en la forma de anillo de lactona cerrado.
ES97101631T Expired - Lifetime ES2186812T3 (es) 1993-01-15 1994-01-14 Tratamiento oral o intramuscular del cancer pancreatico con s-camptotecina insoluble en agua de la forma de anillo de lactona cerrado.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES02015200T Expired - Lifetime ES2301590T3 (es) 1993-01-15 1994-01-14 Utilizacion de camptotecina insoluble en agua en la forma de anillo de lactona cerrado para la obtencion de un medicamento para el tratamiento del cancer de colon.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES97101631T Expired - Lifetime ES2186812T3 (es) 1993-01-15 1994-01-14 Tratamiento oral o intramuscular del cancer pancreatico con s-camptotecina insoluble en agua de la forma de anillo de lactona cerrado.

Country Status (9)

Country Link
EP (3) EP1250926B1 (es)
JP (1) JP3099128B2 (es)
AT (3) ATE165003T1 (es)
CA (1) CA2148822C (es)
DE (3) DE69435084T2 (es)
DK (3) DK1250926T3 (es)
ES (3) ES2301590T3 (es)
PT (1) PT1250926E (es)
WO (1) WO1994015604A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244903A (en) * 1987-03-31 1993-09-14 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
NZ235329A (en) * 1989-09-15 1992-01-29 Res Triangle Inst 20(s or rs)-camptothecin derivatives and pharmaceutical compositions
US5422344A (en) * 1990-05-08 1995-06-06 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Method of treating retroviral infections in mammals
EP0540099B1 (en) * 1991-10-29 1996-04-17 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
EP1393729A3 (en) * 1991-11-15 2004-03-17 Smithkline Beecham Corporation Combination chemotherapy involving topotecan and a platinum coordination compound
CA2125293A1 (en) * 1991-12-10 1993-06-24 Randall Keith Johnson Treatment of colorectal cancer

Also Published As

Publication number Publication date
CA2148822C (en) 2001-03-27
PT1250926E (pt) 2008-06-11
EP1250926A2 (en) 2002-10-23
EP0778024B1 (en) 2002-11-13
DE69435084D1 (de) 2008-04-24
ES2186812T3 (es) 2003-05-16
DE69435084T2 (de) 2009-03-19
CA2148822A1 (en) 1994-07-21
EP1250926A3 (en) 2002-11-20
ATE388706T1 (de) 2008-03-15
EP0778024A1 (en) 1997-06-11
DK0778024T3 (da) 2002-12-23
EP1250926B1 (en) 2008-03-12
DK1250926T3 (da) 2008-07-07
DK0678025T3 (da) 1998-10-07
EP0678025A1 (en) 1995-10-25
ATE227573T1 (de) 2002-11-15
JPH08505626A (ja) 1996-06-18
DE69409633D1 (de) 1998-05-20
DE69431731T2 (de) 2003-03-13
JP3099128B2 (ja) 2000-10-16
WO1994015604A1 (en) 1994-07-21
DE69431731D1 (de) 2002-12-19
ATE165003T1 (de) 1998-05-15
EP0678025B1 (en) 1998-04-15
ES2301590T3 (es) 2008-07-01
DE69409633T2 (de) 1998-08-06

Similar Documents

Publication Publication Date Title
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
DK203787A (da) Praeparat til nasal administrering
ATE352289T1 (de) Mittel zur oralen verabreichung
DK20488A (da) Farmaceutiske praeparater med forlaenget afgivelse
DK678887D0 (da) Farmaceutiske praeparater
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
ATE102830T1 (de) Methode zur behandlung des interstitiellen blasenentzuendung.
DK0498144T3 (da) Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma
ES2093357T3 (es) Metodo de tratamiento de la alopecia.
ES2114681T3 (es) Tratamiento transdermico de cancer con camptotecina insoluble en agua en la forma de anillo de lactona cerrado.
HK1000276A1 (en) Use of bilobalide and derivatives thereof for treating an infection in an individual and pharmaceutical compositions adapted for such use
DE69233773D1 (de) Verwendung von topotecan zur herstellung eines medikaments zur verwendung in der behandlung von ovarialkrebs
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.
AU628492B2 (en) Improvements in chemical compounds

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 678025

Country of ref document: ES